International Journal of Pediatric Otorhinolaryngology Extra
Volume 5, Issue 1 , Pages 9-12 , January 2010

Rhino-orbital mucormycosis—A case report

  • S.P.S. Yadav

      Affiliations

    • Department of ENT, Pt. B.D. Sharma P.G.I.M.S., Rohtak, India
  • ,
  • Anuj Kumar Goel

      Affiliations

    • Saraswathi Institute of Medical Sciences, Hapur 245101, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 9992014141.

Received 4 September 2008 ,Revised 17 December 2008 ,Accepted 18 December 2008.

References 

  1. Schell WA. Histopathology of fungal rhinosinusitis. Otolaryngol. Clin. North Am. 2000;33:251–276
  2. Akoz T, Civelek B, Akan M. Rhinocerebral mucormycosis: report of two cases. Ann. Plast. Surg. 1999;43:309–312
  3. Tryfon S, Stanopoulos I, Kakavelas E, et al. Rhinocerebral mucormycosis in a patient with latent diabetes mellitus: a case report. J. Oral. Maxillofac. Surg. 2002;60:328–330
  4. Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope. 1997;107:855–862
  5. Ruoppi P, Dietz A, Nikanne E, et al. Paranasal sinus mucormycosis: a report of two cases. Acta Otolaryngol. 2001;121:948–952
  6. Damante JH, Fleury RN. Oral and rhinoorbital mucormycosis: case report. J. Oral. Maxillofac. Surg. 1998;56:267–271
  7. Hendrickson RG, Olshaker J, Duckett O. Rhinocerebral mucormycosis: a case of a rare, but deadly disease. J. Emerg. Med. 1999;17:641–645
  8. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol. Clin. North Am. 2000;33:349–365
  9. Ray MS, Kumar V, Jain D, Dubey NK. Rhinoorbital mucormycosis in acute renal failure. Indian Pediatr. 2002;39:381–385
  10. Sugar A. Agents of mucormycosis and related species. Infectious disease and their etiologic agents. In:  Mandell GL,  Bennet JE,  Dolin R editor. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. New York: Churchill Livingstone; 1995;p. 2311–2320
  11. Gregory JE, Golden A, Haymaker W. Mucormycosis of the central nervous system: a report of three cases. Bull. Johns Hopkins Hosp. 1943;73:405–414
  12. Harris JS. Mucormycosis: report of a case. Pediatrics. 1955;16:857–867
  13. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 1982;31:1109–1114
  14. Del Valle Zapico A, Rubio Suarez A, Mellado Encinas P, et al. Mucormycosis of the sphenoid sinus in an otherwise healthy patient. Case report and literature review. J. Laryngol. Otol. 1996;110:471–473
  15. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv. Ophthalmol. 1994;39:3–22
  16. Raj P, Vella EJ, Bickerton RC. Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin—a case report. J. Laryngol. Otol. 1998;112:367–370
  17. Kimura M, Smith MB, McGinnis MR. Zygomyeosis due to Apophysomyces elegans: report of 2 cases and review of the literature. Arch. Pathol. Lab. Med. 1999;123:386–390
  18. Strasser MD, Kennedy RJ, Adam RD. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex. Arch. Intern. Med. 1996;156:337–339

PII: S1871-4048(08)00088-9

doi: 10.1016/j.pedex.2008.12.008

International Journal of Pediatric Otorhinolaryngology Extra
Volume 5, Issue 1 , Pages 9-12 , January 2010